Neurogene Inc.: H.C. Wainwright cuts target price to $60 from $65
NGNE•H.C. Wainwright cut its target price for Neurogene Inc. to $60 from $65.
Related News
EU-US deal on pharmaceutical trade must be respected, EU says
XLV•
Dollar steadies as Waller argues for more rate hikes, inflation up next
TLT•
Deutsche Bank raises Sarepta Therapeutics to hold from sell, target to $18 from $14
SRPT•
CalciMedica Q3 net loss narrows 78% to $1.7 million
CALC•
Gain Therapeutics Q3 net loss narrows 40% to $3.16 million
GANX•